Adaptive Biotechnologies is a biotechnology company specializing immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems.
ADPT
6.96 as of 5/31/23
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 1/4/2018 | Series F-1 | $45MM raised | $XXX.XX | $XXX.XX |
| 5/6/2015 | Series F | $195.1MM raised | $XXX.XX | $XXX.XX |
| 1/22/2015 | Series E1 | $105.12MM raised | $XXX.XX | $XXX.XX |
| 1/21/2015 | Series E | $93.75MM raised | $XXX.XX | $XXX.XX |
| 7/29/2014 | Series D | $107MM raised | $XXX.XX | $XXX.XX |
| 7/9/2013 | Series C | $5.02MM raised | $XXX.XX | $XXX.XX |
| 6/2/2011 | Series B | $5.82MM raised | $XXX.XX | $XXX.XX |
| 3/24/2010 | Series A | $4.55MM raised | $XXX.XX | $XXX.XX |
